Golden Eye (Dibrompropamidine Isetionate)

Golden Eye is an ophthalmic preparation that contains the active ingredient Dibrompropamidine Isetionate. The product is supplied in an ocular dosage form, with strength and specific formulation details not disclosed. It is marketed within the European Union and belongs to the antiseptic drug class, specifically used as an ophthalmic antiseptic to address microbial contamination of the eye.

Golden Eye is indicated for the topical treatment of bacterial eye conditions. It is commonly employed by healthcare professionals to manage ocular infections where an antiseptic approach is appropriate.

- Treatment of bacterial conjunctivitis - Management of mild to moderate eye infections - Adjunct therapy for postoperative ocular care - Prophylaxis against bacterial contamination in contact lens wearers - Supportive care for superficial corneal abrasions with suspected infection

Side effects associated with Golden Eye are generally mild, but patients should be aware of both common and less frequent reactions.

Common: - Transient eye irritation or burning sensation - Mild redness of the conjunctiva - Temporary blurred vision after application - Slight itching or foreign body sensation - Mild tearing

Serious: - Allergic contact dermatitis of the eyelid - Severe ocular inflammation or swelling - Persistent visual disturbance - Development of secondary infection - Corneal ulceration (rare)

Before using Golden Eye, certain precautions should be considered to ensure safe and effective use.

- Verify that the product is intended for ocular use only; do not apply to other mucous membranes. - Discontinue use and seek medical advice if signs of an allergic reaction develop. - Avoid use in patients with known hypersensitivity to dibrompropamidine or related compounds. - Do not use if the packaging is damaged or the solution appears discolored. - Consult an eye care professional before using in conjunction with other ophthalmic medications. - Keep the bottle tightly closed and store at room temperature, away from direct sunlight.

Golden Eye may interact with other ophthalmic agents, influencing efficacy or safety.

Avoid: - Concurrent use with other antiseptic eye drops containing similar active ingredients, which may increase irritation. - Application of mydriatic or cycloplegic agents immediately before or after Golden Eye without a suitable interval.

Use with caution: - Co‑administration with corticosteroid eye drops, as steroids may mask signs of infection. - Use alongside lubricating eye drops; allow a 5‑minute interval between applications. - Patients using contact lenses should remove lenses before instillation and wait before reinserting.